Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca J Leeman-Neill

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Targets|December 22, 2017
BCL6 as a therapeutic target for lymphomaRebecca J Leeman-Neill, Govind Bhagat
Current Hematologic Malignancy Reports|June 27, 2018
Pathogenesis of Enteropathy-Associated T Cell LymphomaUdit Chander, Rebecca J Leeman-Neill, Govind Bhagat
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2018
The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene DiversificationRebecca J Leeman-Neill, Junghyun Lim, Uttiya Basu
Advances in Immunology|May 19, 2024
AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activityRebecca J Leeman-Neill, Govind Bhagat, Uttiya Basu
Archives of Pathology & Laboratory Medicine|June 5, 2026
KMT2A Amplification in Mixed-Phenotype Acute Leukemia: Immunophenotyping, Cytogenomic Features, and Clinical CorrelationMadhulatha Pantrangi, Paul Dylan Barone, Rebecca J Leeman-Neill, et al.
British Journal of Haematology|November 17, 2015
Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC geneSarah E Gibson, Rebecca J Leeman-Neill, Sarika Jain, et al.
The American Journal of Dermatopathology|June 21, 2016
Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin TreatmentWilliam T Johnson, Rebecca J Leeman-Neill, Parth Patel, et al.
Leukemia Research|May 4, 2019
Low-level BCR-ABL1 transcripts in individuals without overt hematologic malignancyRebecca J Leeman-Neill, Steven H Swerdlow, Catherine L Burnes, et al.
Molecular Cancer Therapeutics|July 30, 2009
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell deathChangyou Li, Yan Zang, Malabika Sen, et al.
American Journal of Hematology|September 1, 2020
The clinical and pathological features of plasma cell myeloma post solid organ transplantationKenneth Ofori, Craig R Soderquist, Vundavalli V Murty, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|December 22, 2017
BCL6 as a therapeutic target for lymphomaRebecca J Leeman-Neill, Govind Bhagat
Current Hematologic Malignancy Reports|June 27, 2018
Pathogenesis of Enteropathy-Associated T Cell LymphomaUdit Chander, Rebecca J Leeman-Neill, Govind Bhagat
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2018
The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene DiversificationRebecca J Leeman-Neill, Junghyun Lim, Uttiya Basu
Advances in Immunology|May 19, 2024
AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activityRebecca J Leeman-Neill, Govind Bhagat, Uttiya Basu
Archives of Pathology & Laboratory Medicine|June 5, 2026
KMT2A Amplification in Mixed-Phenotype Acute Leukemia: Immunophenotyping, Cytogenomic Features, and Clinical CorrelationMadhulatha Pantrangi, Paul Dylan Barone, Rebecca J Leeman-Neill, et al.
British Journal of Haematology|November 17, 2015
Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC geneSarah E Gibson, Rebecca J Leeman-Neill, Sarika Jain, et al.
The American Journal of Dermatopathology|June 21, 2016
Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin TreatmentWilliam T Johnson, Rebecca J Leeman-Neill, Parth Patel, et al.
Leukemia Research|May 4, 2019
Low-level BCR-ABL1 transcripts in individuals without overt hematologic malignancyRebecca J Leeman-Neill, Steven H Swerdlow, Catherine L Burnes, et al.
Molecular Cancer Therapeutics|July 30, 2009
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell deathChangyou Li, Yan Zang, Malabika Sen, et al.
American Journal of Hematology|September 1, 2020
The clinical and pathological features of plasma cell myeloma post solid organ transplantationKenneth Ofori, Craig R Soderquist, Vundavalli V Murty, et al.
Pageof 2